These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23216335)

  • 41. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
    Moran C; Arriaga M; Arechavaleta-Velasco F; Moran S
    J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia.
    Papalou O; Livadas S; Karachalios A; Tolia N; Kokkoris P; Tripolitakis K; Diamanti-Kandarakis E
    Hormones (Athens); 2015; 14(1):91-100. PubMed ID: 25553762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
    Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
    Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
    Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of betatrophin with metabolic characteristics in overweight/obese and lean women with PCOS.
    Li L; Zhang F; Cui J; Shi Y; Xiang J; Wang X; Zhao N; Yan Q; Greenberg AS; Peng Y; Ding X
    Gynecol Endocrinol; 2017 Mar; 33(3):238-243. PubMed ID: 27960599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
    Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone.
    Lee MS; Lanes A; Dolinko AV; Bailin A; Ginsburg E
    J Assist Reprod Genet; 2020 Sep; 37(9):2293-2304. PubMed ID: 32623663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
    Alemzadeh R; Kichler J; Calhoun M
    Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.
    Escobar-Morreale HF; Botella-Carretero JI; Villuendas G; Sancho J; San Millán JL
    J Clin Endocrinol Metab; 2004 Feb; 89(2):806-11. PubMed ID: 14764799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
    Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.
    Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
    Li L; Chen X; He Z; Zhao X; Huang L; Yang D
    J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.
    Hahn S; Backhaus M; Broecker-Preuss M; Tan S; Dietz T; Kimmig R; Schmidt M; Mann K; Janssen OE
    Eur J Endocrinol; 2007 Aug; 157(2):201-7. PubMed ID: 17656599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Normal metabolic flexibility despite insulin resistance women with polycystic ovary syndrome.
    Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
    Endocr J; 2013; 60(9):1107-13. PubMed ID: 23801024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment.
    Daskalopoulos G; Karkanaki A; Piouka A; Prapas N; Panidis D; Gkeleris P; Athyros VG
    Curr Vasc Pharmacol; 2015; 13(6):788-800. PubMed ID: 25600030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance.
    Mario FM; do Amarante F; Toscani MK; Spritzer PM
    Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):511-6. PubMed ID: 22576259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.
    El-Mesallamy HO; Abd El-Razek RS; El-Refaie TA
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):178-82. PubMed ID: 23434327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.